186 related articles for article (PubMed ID: 16757557)
1. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.
Zhou J; Pérès L; Honoré N; Nasr R; Zhu J; de Thé H
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9238-43. PubMed ID: 16757557
[TBL] [Abstract][Full Text] [Related]
2. A sumoylation site in PML/RARA is essential for leukemic transformation.
Zhu J; Zhou J; Peres L; Riaucoux F; Honoré N; Kogan S; de Thé H
Cancer Cell; 2005 Feb; 7(2):143-53. PubMed ID: 15710327
[TBL] [Abstract][Full Text] [Related]
3. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
4. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation.
Kamashev D; Vitoux D; De Thé H
J Exp Med; 2004 Apr; 199(8):1163-74. PubMed ID: 15096541
[TBL] [Abstract][Full Text] [Related]
5. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.
Jansen JH; Mahfoudi A; Rambaud S; Lavau C; Wahli W; Dejean A
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7401-5. PubMed ID: 7638205
[TBL] [Abstract][Full Text] [Related]
6. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
[TBL] [Abstract][Full Text] [Related]
7. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
[TBL] [Abstract][Full Text] [Related]
8. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
9. PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.
Katerndahl CDS; Rogers ORS; Day RB; Xu Z; Helton NM; Ramakrishnan SM; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317690121. PubMed ID: 38648485
[TBL] [Abstract][Full Text] [Related]
10. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
Zhu G
Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
[TBL] [Abstract][Full Text] [Related]
11. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.
Lin RJ; Evans RM
Mol Cell; 2000 May; 5(5):821-30. PubMed ID: 10882118
[TBL] [Abstract][Full Text] [Related]
13. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
14. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
15. [RXR, a key member of the oncogenic complex in acute promyelocytic leukemia].
Halftermeyer J; Le Bras M; De Thé H
Med Sci (Paris); 2011 Nov; 27(11):973-8. PubMed ID: 22130024
[TBL] [Abstract][Full Text] [Related]
16. Eya2, a Target Activated by Plzf, Is Critical for
Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
[TBL] [Abstract][Full Text] [Related]
17. RXR is an essential component of the oncogenic PML/RARA complex in vivo.
Zhu J; Nasr R; Pérès L; Riaucoux-Lormière F; Honoré N; Berthier C; Kamashev D; Zhou J; Vitoux D; Lavau C; de Thé H
Cancer Cell; 2007 Jul; 12(1):23-35. PubMed ID: 17613434
[TBL] [Abstract][Full Text] [Related]
18. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
[TBL] [Abstract][Full Text] [Related]
19. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
Le Beau MM; Bitts S; Davis EM; Kogan SC
Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
[TBL] [Abstract][Full Text] [Related]
20. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
